Two sides of the same coin: tyrosine kinase inhibition in cancer and neurodegeneration

por Hebron, Michaeline, Moussa, Charbel E-H
Publicado 2015

TDP-43 overexpression impairs presynaptic integrity

por Heyburn, Lanier, Moussa, Charbel E-H.
Publicado 2016

The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases

por Khandelwal, Preeti J., Moussa, Charbel E-H
Publicado 2010

Ubiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance

por Lonskaya, Irina, Desforges, Nicole M., Hebron, Michaeline L., Moussa, Charbel E-H.
Publicado 2013

Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance

por Lonskaya, Irina, Hebron, Michaeline L, Desforges, Nicole M, Franjie, Alexander, Moussa, Charbel E-H
Publicado 2013

Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases

por Desforges, Nicole M., Hebron, Michaeline L., Algarzae, Norah K., Lonskaya, Irina, Moussa, Charbel E.-H.
Publicado 2012

Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy

por Hebron, Michaeline L., Lonskaya, Irina, Olopade, Paul, Selby, Sandra T., Pagan, Fernando, Moussa, Charbel E-H
Publicado 2014

Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration

por Fowler, Alan J., Hebron, Michaeline, Missner, Alexander A., Wang, Ruchong, Gao, Xiaokong, Kurd-Misto, Bahjat T., Liu, Xiaoguang, Moussa, Charbel E.-H.
Publicado 2019